Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 400 of 467 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 06/22/21
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 05/31/07
Due: 05/31/08
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 10/26/18
End: 04/01/22
Due: 04/01/23
Phase: N/A
Priority: Normal
Start: 06/17/19
End: 04/07/21
Due: 04/07/22
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 06/16/23
End: 06/30/25
Due: 06/30/26
Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
Phase: N/A
Priority: Normal
Start: 12/31/18
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 06/01/27
Due: 06/01/28
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 03/15/22
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 12/11/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/31/98
End: 06/30/01
Due: 06/30/02
Phase: N/A
Priority: Normal
Start: 05/22/17
End: 06/24/20
Due: 06/24/21
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 12/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/99
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 03/31/11
Due: 03/31/12